AMLX Amylyx Pharmaceuticals, Inc.

Fundamentals / CIK 0001658551 / USD

Amylyx Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $163.2M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AMLX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$407.2M$203.6M$0-$314.5MFY 2021 Revenue: $285KFY 2021 Net Income: -$87.93M2021FY 2022 Revenue: $22.23MFY 2022 Net Income: -$198.4M2022FY 2023 Revenue: $380.8MFY 2023 Net Income: $49.27M2023FY 2024 Revenue: $87.37MFY 2024 Net Income: -$301.7M2024FY 2025 Revenue: $0FY 2025 Net Income: -$144.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $87.37M $380.8M $22.23M $285K
Cost of Revenue $0 $5.95M $25.44M $2.99M --
Gross Profit $0 $81.42M $355.3M $19.24M --
Research & Development $90.40M $104.1M $128.2M $93.45M $44.04M
Selling, General & Admin $62.89M $114.3M $188.4M $127.1M $38.93M
Operating Income -$153.3M -$314.7M $38.80M -$201.3M -$82.69M
EBITDA -$152.8M -$313.8M $39.89M -$200.9M -$82.64M
Interest Income $9.30M $13.81M $16.16M $4.29M $36K
Income Before Tax -$144.7M -$302.1M $54.30M -$197.6M -$87.93M
Income Tax Expense $46K -$393K $5.03M $774K --
Net Income -$144.7M -$301.7M $49.27M -$198.4M -$87.93M
Basic EPS -$1.53 -$4.43 $0.73 -$3.39 -$13.35
Diluted EPS -$1.53 -$4.43 $0.70 -$3.39 -$13.35
Basic Shares Outstanding 94.6M 68.1M 67.2M 58.5M 6.6M
Diluted Shares Outstanding 94.6M 68.1M 70.0M 58.5M 6.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $0 -$665K
Cost of Revenue -- -- -- $0 $0 $0 $0 $0
Gross Profit -- -- -- $0 $0 $0 $0 -$665K
Research & Development $28.35M $23.77M $27.61M $21.21M $19.86M $27.22M $22.12M $22.89M
Selling, General & Admin $21.31M $21.93M $16.17M $15.39M $16.17M $15.64M $15.68M $17.10M
Operating Income -$49.66M -$45.69M -$43.78M -$36.60M -$36.03M -$42.86M -$37.80M -$40.65M
EBITDA -$49.62M -$45.65M -$43.68M -$36.50M -$35.91M -$42.72M -$37.65M -$40.49M
Interest Income $4.18M $2.32M $2.57M $3.29M $1.82M $1.96M $2.23M $2.32M
Income Before Tax -- -- -- -$32.95M -$34.39M -$41.44M -$35.91M -$38.18M
Income Tax Expense -- -- -- $46K $0 $0 $0 -$635K
Net Income -$45.49M -$43.42M -$41.28M -$33.00M -$34.39M -$41.44M -$35.91M -$37.55M
Basic EPS -$0.38 -$0.39 -$0.37 -- -$0.37 -$0.46 -$0.42 --
Diluted EPS -$0.38 -$0.39 -$0.37 -- -$0.37 -$0.46 -$0.42 --
Basic Shares Outstanding 118.9M 111.2M 110.6M -- 93.3M 89.1M 85.7M --
Diluted Shares Outstanding 118.9M 111.2M 110.6M -- 93.3M 89.1M 85.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $226.7M $77.39M $170.2M $62.53M $50.19M
Short-Term Investments $90.33M $99.11M $201.2M $284.4M $45.93M
Cash & Short-Term Investments $317.0M $176.5M $371.4M $346.9M $96.12M
Accounts Receivable, Net $88K $447K $40.05M $15.31M --
Inventory -- -- $38.32M $9.77M --
Total Current Assets $323.7M $189.4M $464.7M $382.1M $105.0M
Property, Plant & Equipment, Net $310K $961K $2.69M $2.61M $474K
Other Non-Current Assets $2.50M $24K $701K $466K --
Total Non-Current Assets $8.97M $4.20M $52.79M $9.32M $663K
Total Assets $332.6M $193.6M $517.5M $391.5M $105.6M
Accounts Payable $3.52M $2.94M $22.06M $6.26M $4.37M
Total Current Liabilities $22.69M $28.41M $82.04M $46.61M $17.40M
Total Non-Current Liabilities $4.70M $463K $1.98M $4.24M $35K
Total Liabilities $27.39M $28.87M $84.02M $50.85M $17.43M
Total Debt (incl. Leases) $5.96M $1.98M $4.24M $6.28M --
Common Stock $11K $7.0K $7.0K $7.0K $1.0K
Retained Earnings -$751.4M -$606.7M -$304.9M -$354.2M -$155.8M
Accumulated Other Comp. Income $404K -$92K $197K -$86K $9.0K
Total Stockholders' Equity $305.3M $164.8M $433.4M $340.6M -$151.2M
Total Equity $305.3M $164.8M $433.4M $340.6M -$151.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $240.1M $49.33M $229.1M $226.7M $225.2M $58.09M $59.76M $77.39M
Short-Term Investments $528.0M $201.4M $50.63M $90.33M $118.8M $122.7M $144.3M $99.11M
Cash & Short-Term Investments $768.1M $250.8M $279.8M $317.0M $344.0M $180.8M $204.1M $176.5M
Accounts Receivable, Net -- -- -- $88K $132K $103K $300K $447K
Total Current Assets $778.9M $256.3M $285.0M $323.7M $353.4M $186.9M $216.1M $189.4M
Property, Plant & Equipment, Net $191K $199K $212K $310K $399K $445K $816K $961K
Other Non-Current Assets -- -- $2.50M $2.50M $2.50M -- $11K $24K
Total Non-Current Assets $7.94M $8.23M $8.58M $8.97M $9.36M $7.71M $3.53M $4.20M
Total Assets $786.8M $264.6M $293.6M $332.6M $362.7M $194.6M $219.7M $193.6M
Accounts Payable $4.80M $5.53M $3.53M $3.52M $5.34M $3.29M $4.81M $2.94M
Total Current Liabilities $29.05M $21.15M $15.97M $22.69M $25.79M $21.42M $17.93M $28.41M
Total Non-Current Liabilities $4.01M $4.25M $4.48M $4.70M $4.95M $5.30M $327K $463K
Total Liabilities $33.06M $25.40M $20.44M $27.39M $30.75M $26.72M $18.26M $28.87M
Total Debt (incl. Leases) $4.94M $5.25M $5.63M $5.96M $5.93M $5.96M $1.38M $1.98M
Common Stock $13K $11K $11K $11K $11K $9.0K $9.0K $7.0K
Retained Earnings -$881.6M -$836.1M -$792.7M -$751.4M -$718.4M -$684.0M -$642.6M -$606.7M
Accumulated Other Comp. Income -$179K $19K $240K $404K $815K $551K $0 -$92K
Total Stockholders' Equity $753.7M $239.2M $273.2M $305.3M $332.0M $167.9M $201.4M $164.8M
Total Equity $753.7M $239.2M $273.2M $305.3M $332.0M $167.9M $201.4M $164.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$144.7M -$301.7M $49.27M -$198.4M -$87.93M
Depreciation & Amortization $525K $904K $1.09M $487K $52K
Stock-Based Compensation $27.64M $33.04M $37.16M $21.71M $3.14M
Change in Receivables $359K $39.60M -$24.74M -$15.31M --
Change in Inventory -- -$9.25M -$73.13M -$9.77M --
Change in Payables $580K -$19.10M $15.88M $1.85M $670K
Operating Cash Flow -$123.3M -$167.6M $11.92M -$179.9M -$74.80M
Capital Expenditure -$138K -$157K -$1.24M -$2.53M -$353K
Free Cash Flow -$123.5M -$167.8M $10.68M -$182.4M -$75.15M
Purchases of Investments -$231.8M -$232.0M -$300.8M -$415.9M -$49.05M
Investing Cash Flow $14.04M $75.65M $92.05M -$239.0M -$46.41M
Financing Cash Flow $257.0M $348K $3.54M $431.8M $158.5M
Net Change in Cash $148.8M -$92.08M $107.7M $12.87M $37.31M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$45.49M -$43.42M -$41.28M -$33.00M -$34.39M -$41.44M -$35.91M -$37.55M
Depreciation & Amortization $33K $43K $98K $108K $120K $141K $156K $160K
Stock-Based Compensation $10.37M $8.32M $6.12M $6.39M $7.08M $7.35M $6.83M $6.74M
Change in Receivables -- -- -- $44K -$30K $198K $147K $1.28M
Change in Inventory -- -- -- -- -- -- $0 $0
Change in Payables -$730K $2.00M $10K $275K -$33K -$1.53M $1.87M $1.47M
Operating Cash Flow -$33.67M -$31.42M -$36.88M -$27.90M -$30.37M -$25.25M -$39.82M -$59.01M
Capital Expenditure -- -- -- -$86K -$24K -$17K -$11K -$20K
Free Cash Flow -- -- -- -$27.99M -$30.39M -$25.27M -$39.84M -$59.03M
Purchases of Investments -- -$180.8M -$19.74M -$30.45M -$58.74M -$38.99M -$103.6M $0
Investing Cash Flow -$325.7M -$149.8M $36.26M $29.47M $5.24M $22.99M -$43.66M $64.98M
Financing Cash Flow $550.2M $1.48M $3.22M -$208K $191.6M -$31K $65.66M $110K
Net Change in Cash $190.8M -$179.8M $2.49M $1.48M $166.6M -$1.68M -$17.62M $5.56M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 93.2% 93.3% 86.5% --
Operating Margin -- -360.2% 10.2% -905.7% -29013.3%
Net Profit Margin -- -345.4% 12.9% -892.4% -30853.0%
Return on Equity (ROE) -47.4% -183.1% 11.4% -58.2% --
Return on Assets (ROA) -43.5% -155.8% 9.5% -50.7% -83.3%
Current Ratio 14.27x 6.67x 5.66x 8.20x 6.03x
Quick Ratio 13.98x 6.23x 5.20x 7.99x 5.53x
Debt to Equity 0.02x 0.01x 0.01x 0.02x --
Revenue Growth (YoY) -100.0% -77.1% +1612.9% +7700.0% --
Gross Profit Growth (YoY) -100.0% -77.1% +1747.2% -- --
Operating Income Growth (YoY) -- -911.1% -- -- --
Net Income Growth (YoY) -- -712.4% -- -- --
EPS Growth (YoY) -- -706.8% -- -- --
Operating Cash Flow Growth (YoY) -- -1506.6% -- -- --
Free Cash Flow Growth (YoY) -- -1671.5% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- -- -- 93.2%
Operating Margin -- -- -- -- -- -- -- -360.2%
Net Profit Margin -- -- -- -- -- -- -- -345.4%
Return on Equity (ROE) -21.7% -63.6% -55.0% -47.4% -45.0% -111.7% -108.7% -183.1%
Return on Assets (ROA) -20.7% -57.5% -51.1% -43.5% -41.2% -96.4% -99.6% -155.8%
Current Ratio 26.81x 12.12x 17.85x 14.27x 13.70x 8.72x 12.05x 6.67x
Quick Ratio 26.44x 11.86x 17.52x 13.98x 13.34x 8.45x 11.40x 6.23x
Debt to Equity 0.01x 0.02x 0.02x 0.02x 0.02x 0.04x 0.01x 0.01x
Revenue Growth (YoY) -- -- -- -- -100.0% -- -100.0% -100.6%
Gross Profit Growth (YoY) -- -- -- -- -100.0% -- -100.0% -100.7%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -2202.1%
Net Income Growth (YoY) -- -- -- -- -- -- -- -893.6%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -535.5%
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -547.4%
Source: SEC EDGAR CompanyFacts (CIK 0001658551) · from March 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal